This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2016 Aug;4(8):594-595.

doi: 10.1016/S2213-2600(16)30156-4. Epub 2016 Jun 10.

Personalised medicine in advanced cystic fibrosis

Edward F McKone¹

Affiliations

PMID: 27298016
DOI: 10.1016/S2213-2600(16)30156-4

Comment

Personalised medicine in advanced cystic fibrosis

Edward F McKone. Lancet Respir Med. 2016 Aug.

. 2016 Aug;4(8):594-595.

doi: 10.1016/S2213-2600(16)30156-4. Epub 2016 Jun 10.

Author

Edward F McKone¹

Affiliation

¹ St Vincent's University Hospital, Dublin 4, Ireland. Electronic address: e.mckone@st-vincents.ie.

PMID: 27298016
DOI: 10.1016/S2213-2600(16)30156-4

No abstract available

PubMed Disclaimer

Comment on

Efficacy and safety of lumacaftor/ivacaftor combination therapy in patients with cystic fibrosis homozygous for Phe508del CFTR by pulmonary function subgroup: a pooled analysis.
Elborn JS, Ramsey BW, Boyle MP, Konstan MW, Huang X, Marigowda G, Waltz D, Wainwright CE; VX-809 TRAFFIC and TRANSPORT study groups. Elborn JS, et al. Lancet Respir Med. 2016 Aug;4(8):617-626. doi: 10.1016/S2213-2600(16)30121-7. Epub 2016 Jun 10. Lancet Respir Med. 2016. PMID: 27298017 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- Genetic Alliance
- MedlinePlus Health Information